Boston Scientific Corp.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $1.18B | $806.0M | $376.0M | $116.0M |
| FY2017 | $1.43B | $1.11B | $319.0M | $127.0M |
| FY2018 | $310.0M | $-6.0M | $316.0M | $140.0M |
| FY2019 | $1.84B | $1.38B | $461.0M | $157.0M |
| FY2020 | $1.51B | $1.13B | $376.0M | $170.0M |
| FY2021 | $1.87B | $1.32B | $554.0M | $194.0M |
| FY2022 | $1.53B | $938.0M | $588.0M | $220.0M |
| FY2023 | $2.50B | $1.79B | $711.0M | $233.0M |
| FY2024 | $3.44B | $2.65B | $790.0M | $266.0M |
| FY2025 | $4.53B | $3.66B | $876.0M | $299.0M |